Molecular Docking Studies Involving Transitional Metal Complexes (Zn(II), Co(II), Cu(II), Fe(II), Ni(II) with Cholic Acid (AC) as Ligand against Aurora A Kinase

Abstract:

Article Preview

Colorectal cancer is a malignant tumor, one of the main types of cancer which produces a large number of deaths each year in many countries around the world. The main objective of this work is to employ various bioinformatics tools to perform docking of the transitional metal complexes (Zn (II), Co (II), Cu (II), Fe (II), Ni (II)) with cholic acid (AC) as ligand against Aurora A Kinase (RCSB Protein Data Bank code: 2X6E). Molegro Virtual Docker (MVD) was used for the docking process. The molecular docking score and the values of the statistic parameter Root Mean Square Deviation (RMSD) are presented in Table 1. The results obtained in this study serve to design new complex combinations with potential action against Aurora A Kinase inhibitor.

Info:

Periodical:

Edited by:

Honghua Tan

Pages:

236-240

Citation:

A. Beteringhe et al., "Molecular Docking Studies Involving Transitional Metal Complexes (Zn(II), Co(II), Cu(II), Fe(II), Ni(II) with Cholic Acid (AC) as Ligand against Aurora A Kinase", Advanced Materials Research, Vol. 787, pp. 236-240, 2013

Online since:

September 2013

Export:

Price:

$38.00

[1] S. Gopalakrishnan, E. Vadivel, P. P. Sathieshkumar, M. S. Praba: J. Chem. Pharm. Res. Vol. 2, (2010), p.60.

[2] N. Suvannang, C. Nantassenamat, C. I. Na-Ayudhya, V. Prachayasittikul: Molecules Vol. 16, (2011), p.3597.

[3] S. D. Markowitz; M. M. Bertagnolli: N. Engl. J. Med. Vol. 361, (2009), p.2449.

[4] B. Lu, M. Hu, K. Liu, J. Peng: Toxicol. Vitro Vol. 24 (2010), p.1482.

[5] R. Ando, H. Ikegami, M. Sakiyama, S. Ooike, M. Hayashi, Y. Fujino, D. Abe, H. Nakamura, T. Mishina, H. Kato, Y. Iwase, H. Tomozane, M. Morioka: Bioorg. Med. Chem. Lett. Vol. 20, (2010), p.4709.

DOI: https://doi.org/10.1016/j.bmcl.2010.04.119

[6] A. H. Kishore, B. M. Vedamurthy, K. Mantelingu, S. Agrawal, B. A. Ashok Reddy, S. Roy, K. S. Rangappa, T. K. Kundu: J. Med. Chem. (2008), p.792.

[7] Y. Ai, S. T. Wang, P. H. Sun, F. J. Song: Int. J. Molec. Sci, Vol. 12, (2011), p.1605.

[8] G. Gautschi, J. Heighway, P. C. Mack, P. R. Purnell, P. N. Lara, D. R. Gandara: Clin. Cancer Res. Vol. 14, (2008), p.1639.

[9] J. R. Pollard, M. J. Mortimore: Med. Chem. Vol. 52, (2009), p.2629.

[10] H. Katayama, S. Sen: Biochim. Biophys. Acta, Vol. 10-12, (2010), p.829.

[11] E.P. Semighini, J. Resende, P. Andrade, P.A.B. Morais, I. Carvalho, C.A. Taft, C.H.T.P. Silva: J. Biomol. Struct. Dynam. Vol. 28, (2011), p.787.

[12] M. A. Thompson, ACS meeting, Philadelphia, 172, CINF 42, PA, (2004).

[13] Hyperchem Professiobal 8. 0 (evaluation version), Copyright © 1995-2011 Hypercube, Inc., http: /www. hyper. com/?tabid=360, (accessed on 02 December 2012).

[14] D. C. Culita, L. Patron, G. Marinescu, T. Constantinescu, R. Alexandrova, G. Rashkova: Rev. Roum. Chim., Vol. 50, (2005), p.745.

[15] V. Bavetsias, J. M. Large, C. Sun, N. Bouloc, M. Kosmopoulou, M. Matteucci, N. E. Wilsher, V. Martins, J. Reynisson, B. Atrash, A. Faisal, F. Urban, M. Valenti, A. De Haven Brandon, G. Box, F. I. Raynaud, P. Workman, S. A. Eccles, R. Bayliss, J. Blagg, S. Linardopoulos, E. Mcdonald: J. Med. Chem. Vol. 53, (2010).

DOI: https://doi.org/10.1021/jm100262j

[16] a) R. Thomsen, M. H. Christense, Moldock: J. Med., Vol. 49, (2006), p.3315. b) B.S. Reddy, C.V. Rao, K. Seibert: Cancer Res. Vol. 56, (1996) p.4566.

[17] G. Ratnavali, N. K. D. Devi, K. B. Sri, J. K. Raju, B. Sirisha, R. Kavitha: Ann. Biol. Res., Vol. 2, (2011), p.114.

Fetching data from Crossref.
This may take some time to load.